Apple researchers have developed MVICAD2, a new machine learning technique for analyzing brain signals recorded from multiple people simultaneously.
Unlike older methods that assume everyone's brain activity is identical, MVICAD2 accounts for individual differences in both the timing and speed of neural responses.
The team validated the approach on a publicly available aging dataset, showing that these timing differences are linked to age—a finding that could help neuroscience research better understand how brain dynamics change over time.
What happened
Apple researchers introduced MVICAD2, a machine learning method that analyzes brain signals (magnetoencephalography data) from multiple subjects by accounting for both temporal delays and dilations in neural activity. The approach improves upon existing Multi-View Independent Component Analysis methods by allowing source signals to differ across subjects in timing and speed, validated using the Cam-CAN dataset and showing how these differences relate to aging.
Why it matters
Brain imaging studies often assume identical neural sources across subjects, but individual variability—including age-related changes—makes this assumption unrealistic. MVICAD2 addresses this gap, potentially enabling more accurate group-level neuroscience analysis and better understanding of how brain dynamics vary with age, which could inform clinical and research applications.
What to watch
The research demonstrates superiority over existing multi-view independent component analysis methods in simulations; practical adoption will depend on how neuroscience labs and clinical researchers integrate the technique into their pipelines.
Ask the AI about this article →
Multi-view machine learning—analyzing data from multiple sources simultaneously—has long struggled with integration of heterogeneous data and alignment of feature spaces across subjects. In neuroscience, this challenge is particularly acute: group-level studies of brain activity typically assume that neural sources are identical across all participants, an assumption the body identifies as often too restrictive given individual variability and age-related changes. Earlier techniques like Multi-View Independent Component Analysis and Multi-View Independent Component Analysis with Delays made progress by relaxing some constraints, but temporal dilation effects—variations in the speed at which neural responses unfold—remained unaddressed. MVICAD2 fills this gap by jointly modeling both delays and dilations, supported by a mathematically identifiable model with a closed-form likelihood approximation. The validation on the Cam-CAN dataset, showing correlation between delays/dilations and aging, suggests that accounting for these variations is not merely a technical improvement but clinically and scientifically meaningful.
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytime
Ask AI anything about this article. Q&As are published on this page for other readers too.
Astromech, an AI startup co-founded by Ben Lamm and geneticist George Church, raised $20 million in funding le…
Bristol Myers Squibb (BMS) has partnered with Chai Discovery, an AI company, to use artificial intelligence fo…
Tempus AI's stock surged following a Merck and Moderna cancer trial that demonstrated positive results using P…
Mayo Clinic appointed Arun Kumar Bhaskara-Baba as Chief Information Officer in May, succeeding Cris Ross who r…
Aily Labs, an AI Decision Intelligence platform company, partnered with Google Cloud to make its platform avai…
The global protein design and engineering market is projected to grow from $7.62 billion in 2025 to $8.79 bill…
